Venture Challenge winner SeraNovo is proud to announce that in December 2021, Carna Biosciences initiated a clinical study with a drug product based on a joint development program with SeraNovo's eutectic formulation technology.
Following the successful first edition in 2021, Stichting Proefdiervrij is organising the second edition of the Proefdiervrij Venture Challenge from February - April 2022. During the Proefdiervrij Venture Challenge, these teams of researchers, are g
In 2014, Prolira participated in the Venture Challenge as a start-up. Now, years later, the announcement has been made that several parties together invest €5 million in the scale-up to further help hospital departments improve patient care in the field of acute brain failure (acute encephalopathy and delirium).
Are you the next emerging biotech entrepreneur in the Netherlands? And do you want access to experienced life science mentors, networking with fellow peer entrepreneurs and do you want to have an inside look in the Massachusetts life sciences sector?